| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217690 |
| MINT-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217693 |
| MINT-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217696 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 40MG 5MG | TABLET | Resolved | 2025-06-17 | 2025-07-21 | 260513 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2025-04-23 | 2025-07-21 | 255415 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 40MG 10MG | TABLET | Resolved | 2025-07-09 | 2025-07-21 | 262287 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2024-01-30 | 2024-08-27 | 217876 |
| MYLAN-ATORVASTATIN | 80MG | TABLET | Resolved | 2020-04-02 | 2020-05-26 | 110438 |
| MYLAN-ATORVASTATIN | 10MG | TABLET | Avoided shortage | 2018-07-31 | 2018-10-09 | 57023 |
| MYLAN-ATORVASTATIN | 20MG | TABLET | Resolved | 2017-10-13 | 2018-10-16 | 25898 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53324 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53321 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53318 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53306 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53303 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53300 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53297 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53294 |